Victory Capital Management
MBX

Victory Capital Management’s MBX Biosciences MBX Stock Holding History

Victory Capital Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Buy
+71,028
New +$2.42M ﹤0.01% 1585

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Victory Capital Management's MBX Position: Q1 2026 in Review

Victory Capital Management opened a new position in MBX Biosciences (MBX) in Q1 2026: 71,028 shares worth $2.12M. The stake represents ﹤0.01% of the portfolio and ranks #1585 among its holdings.

157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Victory Capital Management held 71,028 shares of MBX Biosciences worth $2.12M as of Q1 2026.
  • MBX Biosciences was a new Victory Capital Management position in Q1 2026.
  • MBX Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1585 holding.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.